J. Scranton

Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials.

N. Stollenwerk, K. Yoneda, K. Wilner, 2017, Clinical lung cancer.

Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.

Keunchil Park, S. Novello, M. Krzakowski, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer

F. Saad, H. Pandha, D. Petrylak, 2014, Clinical Cancer Research.

Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.

Keunchil Park, S. Novello, M. Krzakowski, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.